ReviewCold Spring Harbor perspectives in medicine2013
Management of the thalassemias.
Review in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Thalassemia in Sub-Saharan Africa: epidemiology, diagnosis, and management - a narrative review.Annals of medicine and surgery (2012) · 2025Review
- The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34Viruses · 2022Article
- The transfusion management of beta thalassemia in the United States.Transfusion · 2021Review
- Challenges in chronic transfusion for patients with thalassemia.Hematology. American Society of Hematology. Education Program · 2020Review
- Thalassemia: Common Clinical Queries in Management.Indian journal of pediatrics · 2020Review
- Clinical Usefulness of Furosemide to Prevent Volume Overload Among Children and Young Adults with Transfusion-Dependent Thalassemia: A Randomized, Open-Label, Crossover Study.Journal of blood medicine · 2020Article
- Managing the need to tell: Triggers and strategic disclosure of thalassemia major in Singapore.American journal of medical genetics. Part A · 2019Article
- Information Technology-Assisted Treatment Planning and Performance Assessment for Severe Thalassemia Care in Low- and Middle-Income Countries: Observational Study.JMIR medical informatics · 2019Article
- Article
- Current understanding of iron homeostasis.The American journal of clinical nutrition · 2017Review
- The Regulation of Iron Absorption and Homeostasis.The Clinical biochemist. Reviews · 2016Review
- Recent trends in the gene therapy of β-thalassemia.Journal of blood medicine · 2015Review
- The hemoglobin E thalassemias.Cold Spring Harbor perspectives in medicine · 2012Review
- β-thalassemia intermedia: a clinical perspective.Cold Spring Harbor perspectives in medicine · 2012Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the last 30 years, in addition to the considerable progress made in control and prevention of thalassemias(3), there have also been major advances in their symptomatic management, at least in wealthier countries where appropriate facilities are available. Remarkable improvements in survival in the severe forms of thalassemia have followed the more judicious use of blood transfusion and, in particular, the ability to manage the iron accumulation resulting from transfusion with its severe and ultimately lethal effects on endocrine and cardiac function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.